Dr. Choi received his undergraduate degree in Biochemistry from Harvard University where he completed his undergraduate thesis with Yang Shi. He then enrolled in the MD PhD program at Yale University completing his graduate work in Immunobiology with Jordan Pober. After completing his residency in dermatology at Yale, he completed a postdoctoral fellowship in Genetics with Richard Lifton.

His lab utilizes high-dimensional genomic, transcriptomic, and immunological assays to elucidate the pathophysiology of skin cancers. The goal is to identify the molecular mechanisms underlying disease initiation, disease progression, and resistance to therapy. In doing so, the group hopes to elucidate why and how clinical differences occur among patients with the same disease. The ultimate objective is to develop novel therapies for patients who need it most, i.e. those who fail to respond to standard-of-care therapies.

Dr. Choi practices dermato-oncology with a special interest in skin cancers (i.e. cutaneous lymphomas, merkel cell carcinoma, melanoma) and graft versus host disease.